about
The promise of immunotherapy in head and neck squamous cell carcinomaClinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinomaTargeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC)Targeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectivesCetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids.The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisHigh level of Tregs is a positive prognostic marker in patients with HPV-positive oral and oropharyngeal squamous cell carcinomas.Effect of the premalignant and tumor microenvironment on immune cell cytokine production in head and neck cancer.Oral epithelial stem cells - implications in normal development and cancer metastasis.Inflammasome activation is critical to the protective immune response during chemically induced squamous cell carcinoma.FOXP3 subcellular localization predicts recurrence in oral squamous cell carcinoma.Therapeutic antitumor efficacy of tumor-derived autophagosome (DRibble) vaccine on head and neck cancer.Elevated levels of 1-hydroxypyrene and N'-nitrosonornicotine in smokers with head and neck cancer: A matched control study.Tumors Alter Inflammation and Impair Dermal Wound Healing in Female Mice.Increased sMICA and TGFβ1 levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells.Decreased NK cells in patients with head and neck cancer determined in archival DNA.Invariant NKT cells are resistant to circulating CD15+ myeloid-derived suppressor cells in patients with head and neck cancer.Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinomaSkewed distribution of IL-7 receptor-α-expressing effector memory CD8+ T cells with distinct functional characteristics in oral squamous cell carcinoma.Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen.Immune cell infiltration patterns and survival in head and neck squamous cell carcinomaBronchial airway gene expression in smokers with lung or head and neck cancer.Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotypeThe tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.Immune alterations and immunotherapy prospects in head and neck cancer.The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.Lentiviral vector-based therapy in head and neck cancer (Review)Novel treatments for head and neck squamous cell carcinoma: preclinical identification and clinical investigation.Elucidating drivers of oral epithelial dysplasia formation and malignant transformation to cancer using RNAseq.Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma.Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options.Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy.Increased frequency and suppressive activity of CD127(low/-) regulatory T cells in the peripheral circulation of patients with head and neck squamous cell carcinoma are associated with advanced stage and nodal involvement.Detection of human polyomaviruses MCPyV, HPyV6, and HPyV7 in malignant and non-malignant tonsillar tissues.Change in CD3ζ-chain expression is an independent predictor of disease status in head and neck cancer patients.The Expression and Relationship of CD68-Tumor-Associated Macrophages and Microvascular Density With the Prognosis of Patients With Laryngeal Squamous Cell Carcinoma.Emerging drugs for head and neck cancer.The cancer-testis antigen, sperm protein 17, a new biomarker and immunological target in head and neck squamous cell carcinoma.Macrophages and prognosis of oral squamous cell carcinoma: A systematic review.
P2860
Q26744433-83C23C99-EF55-41F0-A07D-B96215F36E09Q26752515-83DA56CA-EB3D-4C68-89D0-9F6AC98FD982Q26765429-70B57329-A8BC-422D-BE64-EC9B5E0D63B4Q26770039-29110467-0D62-4272-9CBA-65704824A6BEQ27329648-52BE596C-B3CE-4393-B517-9BB1478E8079Q28388257-74EE9ECD-5866-4E4E-A8DB-B6B48B3ADAE5Q33597525-202F6EB8-CE2D-4FD4-AD16-CCCB01ACA809Q33820247-7CF7E06F-E14E-4693-A7E7-1A353114E435Q34147649-4C18FDF5-EDAF-4962-BD58-7B34FBE0FF8DQ34275796-905EF68D-599D-42AF-9E48-3B721C9F29F1Q34972625-C03043E5-C051-44CC-91E4-CDF2201843FEQ35189742-1EE57AA8-AC9A-467C-840A-B635674A89CFQ35566185-93656785-D588-4D3E-9317-1F23A5AC748CQ36109235-472BA445-76EF-4232-925C-B4762EACB184Q36110266-C409E0B9-74B2-4CE6-9C68-8413CB6AE10FQ36405942-5D6A0967-4B89-4B66-BBFA-D04E0E02E461Q36746282-2C3D5EFF-BC28-4CFD-9A23-92E236369883Q36823719-7C8688EE-4716-4C33-9DEB-08CCC535D0A5Q37248229-F508D02D-93D2-4917-B983-D65F4951FC8CQ37509713-225FF2D3-F51C-47BC-AE25-3A105DFC7A15Q37634052-E96E6EFE-412A-4357-9046-595E1E021711Q37692604-95264283-CB91-42F3-9775-478975347CFFQ37703387-021A26B7-DEF8-4ADB-9FAF-FA6B87343625Q37714302-8936CA2E-8B22-4743-A18A-8F28B0C20A9CQ38079588-4C410F6C-36CE-4A8B-AFA3-FCD1CC610E9DQ38116067-1002AA4D-81EE-456C-88D8-3FC09BD1CF78Q38161874-BEB900DA-5FDD-4290-A2F1-90F810C01210Q38172153-C05D9AC7-C9B8-46D0-AAB9-0460CC0DCB7CQ38221292-2EF685B0-332F-4E1A-A597-B39FC811840CQ38261799-CB007937-C368-4F3B-88B1-4AAA51A84BEFQ39190801-2129FE8E-55B1-495A-83EE-F7492301467DQ39308337-BC89FF9E-90B8-46A6-9AF7-E285FA5CB240Q39328588-AA8F8C15-EC40-46DD-B781-4BA335BBACA1Q39390853-48B2F0ED-D702-497D-8874-4DA9F5C99BA7Q40528120-F9D243B5-D600-428B-B141-34F300799876Q40903579-B9665751-DF81-49C3-9CAF-36EFBBFF6396Q41284044-86A33322-9EEF-4C04-AC8A-39E48C025394Q45874449-CB773237-E9AA-4994-B2C5-B23FB11811AFQ47289028-3E1B514B-A4AA-4E1A-B72C-29CFFE8EC373Q48303782-F4474041-58E8-4354-BC2B-3BC38416C5B5
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Immune suppression in head and neck cancers: a review
@ast
Immune suppression in head and neck cancers: a review
@en
Immune suppression in head and neck cancers: a review
@nl
type
label
Immune suppression in head and neck cancers: a review
@ast
Immune suppression in head and neck cancers: a review
@en
Immune suppression in head and neck cancers: a review
@nl
prefLabel
Immune suppression in head and neck cancers: a review
@ast
Immune suppression in head and neck cancers: a review
@en
Immune suppression in head and neck cancers: a review
@nl
P2093
P2860
P356
P1476
Immune suppression in head and neck cancers: a review
@en
P2093
Anaëlle Duray
Pascale Hubert
Philippe Delvenne
Stéphanie Demoulin
Sven Saussez
P2860
P304
P356
10.1155/2010/701657
P5008
P577
2010-01-01T00:00:00Z
2011-03-10T00:00:00Z